Heart Disease Journals

Cardiology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Yamaoka–Tojo M et al. – Ezetimibe as add–on therapy to statin might be a therapeutic good option for high–risk patients with atherosclerosis.

Related Articles

Efficacy and Safety of Ezetimibe Plus Orlistat or Rimonabant in Statin-Intolerant Nondiabetic Overweight/Obese Patients With Dyslipidemia
Journal of Cardiovascular Pharmacology and Therapeutics, 11/12/09    Relevance Score: 67%

Co-administration of ezetimibe and a statin in management of dyslipidemias: a meta-analysis of clinical trials
Archives of Medical Science, 11/02/09    Relevance Score: 67%

Systematic Review: Comparative Effectiveness and Harms of Combination Therapy and Monotherapy for Dyslipidemia
Annals of Internal Medicine, 11/03/09    Relevance Score: 66%

The Impact of Ezetimibe on Endothelial Function and Other Markers of Cardiovascular Risk
Annals of Pharmacotherapy, 11/18/09    Relevance Score: 44%

Impact of fixed-dose and multi-pill combination dyslipidemia therapies on medication adherence and the economic burden of sub-optimal adherence
Current Medical Research and Opinion, 10/05/09    Relevance Score: 43%


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address